The store will not work correctly when cookies are disabled.
US9475795, 84
ID: ALA3905662
PubChem CID: 72551108
Max Phase: Preclinical
Molecular Formula: C17H23ClN4O4S
Molecular Weight: 414.92
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cc(Cl)cnc1OC1CCN(S(=O)(=O)c2c(C)nn(C)c2C)CC1
Standard InChI: InChI=1S/C17H23ClN4O4S/c1-11-16(12(2)21(3)20-11)27(23,24)22-7-5-14(6-8-22)26-17-15(25-4)9-13(18)10-19-17/h9-10,14H,5-8H2,1-4H3
Standard InChI Key: HXYYINKUXKDVIA-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
3.6387 -0.8963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6003 -1.4977 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 2.7000 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0031 -3.0008 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.3039 -3.7494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3092 -5.2494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6108 -5.9949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9072 -5.2404 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.9020 -3.7404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6004 -2.9949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2096 -5.9864 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-6.2465 -5.3824 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.2052 -4.7864 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.2157 -7.4872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0057 -8.3519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8651 -7.9789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4751 -9.7765 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.9751 -9.7704 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.6844 -10.7383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4327 -8.3419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.5702 -7.9596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 1 0
5 7 2 0
7 8 1 0
8 9 2 0
9 3 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 11 1 0
14 17 1 0
17 18 2 0
17 19 2 0
17 20 1 0
20 21 1 0
21 22 1 0
21 23 2 0
23 24 1 0
24 25 1 0
24 26 1 0
26 20 2 0
26 27 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 414.92 | Molecular Weight (Monoisotopic): 414.1129 | AlogP: 2.33 | #Rotatable Bonds: 5 |
Polar Surface Area: 86.55 | Molecular Species: NEUTRAL | HBA: 7 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 2.18 | CX LogP: 1.26 | CX LogD: 1.26 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.75 | Np Likeness Score: -1.93 |
References
1. (2016) Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases, |